APA (7th ed.) Citation

A, O., SS, J., GS, A., JT, M., & JJ, W. (2022). Medicare Part D Prescription Claims for Brodalumab: Analysis of Annual Trends for 2017-2019. Cutis, 110(4), 212. https://doi.org/10.12788/cutis.0625

Chicago Style (17th ed.) Citation

A, Oulee, Javadi SS, Ahn GS, Maul JT, and Wu JJ. "Medicare Part D Prescription Claims for Brodalumab: Analysis of Annual Trends for 2017-2019." Cutis 110, no. 4 (2022): 212. https://doi.org/10.12788/cutis.0625.

MLA (9th ed.) Citation

A, Oulee, et al. "Medicare Part D Prescription Claims for Brodalumab: Analysis of Annual Trends for 2017-2019." Cutis, vol. 110, no. 4, 2022, p. 212, https://doi.org/10.12788/cutis.0625.